RE:RE:So my follow Mushrooms how is that FDA approval going???StevenBirch wrote: Vestor I was one of those who repeated the idea of the non-approval approval but I think someone at the time quoted the FDA guidelines. But you are right, either way we should hear something from the company.
I'm betting Monday and if I'm wrong then I'm betting Tuesday ...
vestor111 wrote:
Just curious. I did believe many of you when you said the approval was kind of a back-in process (ie if we don't object, go ahead with the trial. A great solution for bureacratic malaise if you think about it...you know rather than wait for months not knowing if any one lifted a finger...)
Anyway I still believe you all (or willing want to)... so why hasn't the company bothered to make this clear to the wider world? Still waiting on the ink to dry on partnerships in the US???
I don't know - I thought I would throw it out there. Jump ball! Insights? - humorous guesses only - it is Friday afterall. And yeah yeah - I get it - Kick off Monday with a bang and all that...
(I asume everyone gets the Mushroom reference - you are kept in the dark and fed horse manure.)
Happy trails - looks like a good raking weekend. :-)
Wow, for 5 years now I have watched memebrs of this board try to nail down timelines for everything. ITA approvals, REB decisions, even phase 1 treatment and outcome results for each patient (down to the exact dates). I am part guilty as well. But my point is that not once have we been even close to being correct. We should really learn something from this.
FDA should not be a problem in my opinion, especially becasue they meetings with them prior to submission. Time will tell. Let's just hope it happens in November or else it will not happen until 2020 in my opinion.
On another note, Kipton was not a huge loss. Shawn seemed to me to be more polished and appropriate for the CEO position. LEts see what they do moving forward.
MAcer